Moxifloxacin
11/0078
Phase 3 small_molecule active
Quick answer
Moxifloxacin for Chronic Obstructive Pulmonary Disease (COPD). is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Chronic Obstructive Pulmonary Disease (COPD).
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active